Related Experiment Video
Updated: Feb 12, 2026

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Transatrial implantation of a transcatheter heart valve for severe mitral annular calcification
Fabien Praz1, Omar K Khalique1, Raymond Lee2
1New York-Presbyterian Hospital/Columbia University Medical Center, New York, NY.
Insights
Transcatheter heart valve (THV) implantation via the atrium is technically successful for severe mitral annular calcification (MAC). However, this high-risk patient group experienced high 30-day mortality, indicating a need for careful patient selection.
Area of Science:
- Cardiovascular Surgery
- Interventional Cardiology
- Biomaterials Science
Background:
- Severe mitral annular calcification (MAC) presents significant challenges for mitral valve repair or replacement.
- Transcatheter heart valve (THV) technology offers a less invasive option for high-risk patients.
Purpose of the Study:
- To assess the outcomes of transatrial implantation of a THV for mitral valve disease in patients with severe MAC.
- To evaluate the technical success and safety of this novel approach.
Main Methods:
- A balloon-expandable THV was implanted via a transatrial approach under cardiopulmonary bypass.
- Anterior mitral valve leaflet resection and pledgeted sutures were used to enhance stability and reduce paravalvular leak.
- Twenty-six high-risk patients with severe MAC were included across six centers.
Main Results:
- Technical success was achieved in all patients, with a significant reduction in mean transmitral gradient.
- Post-procedure mitral regurgitation was trace or mild in all patients.
- Hospital mortality was 19%, and 30-day all-cause mortality was 27%.
Conclusions:
- Transatrial THV implantation is technically feasible for severe MAC, even with complex anatomy.
- The early experience in very high-risk patients demonstrated high 30-day mortality.
- Patients with chronic kidney disease and those undergoing multiple valve surgeries may be at particularly high risk.
Objective:
To assess the outcomes of transatrial implantation of a transcatheter heart valve (THV) for the treatment of mitral valve disease with severe mitral annular calcification (MAC).
Methods:
Implantation of a balloon-expandable THV was performed on cardiopulmonary bypass via left atrial exposure in patients considered at risk for left ventricular outflow tract obstruction. The anterior mitral valve leaflet was systematically resected and pledgeted sutures were placed to enhance stability and reduce paravalvular leak.
Results:
Twenty-six consecutive symptomatic patients with severe MAC (mean age, 78 ± 7 years; 92% female; mean Society of Thoracic Surgeons score, 9.4 ± 4.8) were included at 6 different centers. Two patients (8%) received an Edwards Sapien XT (Edwards Lifesciences, Irvine, Calif), and 24 (92%) an Edwards Sapien 3 bioprosthesis (Edwards Lifesciences). Concomitant aortic valve replacement was performed in 11 patients. Technical success according to the criteria of the Mitral Valve Academic Research Consortium was achieved in all patients. The mean transmitral gradient decreased from 10 ± 5 to 4 ± 2 mm Hg (P < .001) with trace or mild regurgitation in all patients. An elevated mean transaortic gradient (30 mm Hg) was observed in 1 patient (4%). Five patients died during hospital stay (19%) and 2 additional between discharge and 30 days (30-day mortality: 27%). Sustained functional improvement was observed in the remaining patients.
Conclusions:
Transatrial implantation of a THV for the treatment of MAC is associated with high technical success despite unfavorable anatomy. In this early experience of very high surgical risk patients, 30-day all-cause mortality was high. Patients at particular risk appear to be those with chronic kidney disease requiring multiple valve surgery.
Related Concept Videos
Mitral Valve Prolapse I: Introduction
Heart Valves
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
Mitral Valve Prolapse II: Assessment and Management
Mitral Valve Prolapse III: Nursing Management
Anatomy of the Heart
Mitral Stenosis I: Introduction

